NOF (4403) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
5 Jun, 2025Executive summary
Net sales for the nine months ended December 31, 2024, rose 6.9% year-on-year to ¥171,170 million, with operating profit up 7.5% to ¥35,759 million and profit attributable to owners of parent up 6.2% to ¥27,627 million.
The business environment was marked by global economic uncertainty, high interest rates in the US and Europe, and stagnation in the Chinese real estate market, but domestic conditions in Japan showed gradual recovery.
Management focused on expanding business, developing new products, improving productivity, and promoting CSR under the 2025 Mid-Term Management Plan.
Financial highlights
Gross profit for the nine months was ¥64,690 million, up from ¥60,429 million year-on-year.
Ordinary profit increased 5.2% year-on-year to ¥37,606 million.
Basic earnings per share for the period was ¥116.14 (post-share split basis).
Total assets as of December 31, 2024, were ¥344,908 million, with net assets at ¥275,528 million and an equity-to-asset ratio of 79.6%.
Comprehensive income declined 19.2% year-on-year to ¥26,267 million, mainly due to a decrease in valuation difference on available-for-sale securities.
Outlook and guidance
Full-year forecast for FY2025 remains unchanged: net sales ¥239,000 million (+7.5% YoY), operating profit ¥43,000 million (+2.0%), ordinary profit ¥43,800 million (−3.9%), and profit attributable to owners of parent ¥34,900 million (+2.7%).
Dividend forecast for FY2025 is ¥42.00 per share (post-share split basis).
Management notes actual results may differ from forecasts due to various factors.
Latest events from NOF
- Net sales up, profits down; strong explosives growth; dividend and share buyback increased.4403
Q3 202613 Feb 2026 - Profits fell but full-year outlook and shareholder returns were raised on segment growth.4403
Q2 202618 Nov 2025 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 20266 Aug 2025 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 202513 Jun 2025 - Strong Q1 profit growth driven by Functional Chemicals; full-year outlook maintained.4403
Q1 202513 Jun 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 20256 Jun 2025